
<?xml version='1.0' encoding='UTF-8'?>
<article>
<front>
<journal-meta>
<journal-id journal-id-type='publisher'>IJRAP</journal-id>
<journal-title>International Journal of Research in Ayurveda and Pharmacy</journal-title>
<issn pub-type='ppub'>2277-4343</issn>
 <publisher>
<publisher-name>Moksha Publishing House </publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type='other'>10.7897/2277-4343.166229</article-id>
<title-group>
<article-title>MODERNIZING THE TRADITION OF DHUMAPANA BY NEBULIZATION IN RESPIRATORY DISORDERS: A REVIEW ARTICLE
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type='author'>
<name>Angel Grace Chacko</name>
</contrib>
<contrib contrib-type='author'>
<name> Arun Pratap *</name>
</contrib>
<contrib contrib-type='author'>
<name> Aparna Chandran</name>
</contrib>
</contrib-group>
<pub-date>
<month>11</month>
<year>-0001</year>
</pub-date>
<fpage>144</fpage>
<lpage>147</lpage>
<abstract><title>Abstract</title>
Respiratory diseases are major global health concern and it is expected to rise due to increasing urbanization and air pollution.  This conditions significantly impair quality of life, as the patient has ongoing stress and fear of exacerbations. Modern medicine has made substantial advances in treatment of respiratory ailments, particularly through inhalation therapies like nebulization. Despite the efficacy of contemporary inhalation treatments, the use of inhaled corticosteroids (ICS) is associated with localized side effects, including viral gastroenteritis and oral candidiasis. Ayurvedic physicians were managing the respiratory ailments since time unknown and its contribution to worldwide development of inhalation therapy as Dhumapana (therapeutic smoke inhalation) cannot be unseen. But Dhumapana had not got extensive development in terms of technological advancement.  Therefore, integrating traditional Ayurvedic formulations such as Arka Kalpana (ayurvedic distillates), the Dhumapana procedure, and modern technologies like nebulizers and pressurized metered-dose inhalers (pMDI) presents a promising therapeutic approach for the management of respiratory disorders.
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>Nebulization</kwd>
<kwd> respiratory disorders</kwd>
<kwd> Dhumapana</kwd>
<kwd> Swasa</kwd>
<kwd> Arka Kalpana.</kwd>
</kwd-group>
<counts><ref-count count='0'/><page-count count='25'/></counts>
</article-meta></front><back><ref-list><title>References</title></ref-list></back></article>
